1-3 of 3
Beverly D. Smolich
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo

Anne-Marie O'Farrell, Tinya J. Abrams, Helene A. Yuen, Theresa J. Ngai, Sharianne G. Louie, Kevin W. H. Yee, Lily M. Wong, Weiru Hong, Leslie B. Lee, Ajia Town, Beverly D. Smolich, William C. Manning, Lesley J. Murray, Michael C. Heinrich, Julie M. Cherrington
Journal: Blood
Blood (2003) 101 (9): 3597–3605.
https://doi.org/10.1182/blood-2002-07-2307
Published: 2003
Journal Articles

SU5416 and SU5614 inhibit kinase activity of wild-type and mutant FLT3 receptor tyrosine kinase

Kevin W. H. Yee, Anne Marie O'Farrell, Beverly D. Smolich, Julie M. Cherrington, Gerald McMahon, Cecily L. Wait, Laura S. McGreevey, Diana J. Griffith, Michael C. Heinrich
Journal: Blood
Blood (2002) 100 (8): 2941–2949.
https://doi.org/10.1182/blood-2002-02-0531
Published: 2002
Journal Articles

The antiangiogenic protein kinase inhibitors SU5416 and SU6668 inhibit the SCF receptor (c-kit) in a human myeloid leukemia cell line and in acute myeloid leukemia blasts

Beverly D. Smolich, Helene A. Yuen, Kristina A. West, Francis J. Giles, Maher Albitar, Julie M. Cherrington
Journal: Blood
Blood (2001) 97 (5): 1413–1421.
https://doi.org/10.1182/blood.V97.5.1413
Published: 2001